Statin Use Decreases the Incidence of Hepatocellular Carcinoma: An Updated Meta-Analysis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Statin Use Decreases the Incidence of Hepatocellular Carcinoma: An Updated Meta-Analysis
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 4, Pages 874
Publisher
MDPI AG
Online
2020-04-07
DOI
10.3390/cancers12040874
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of Hypercholesterolemia and Statin Exposure on Survival in a Large National Cohort of Patients With Cirrhosis
- (2019) David E. Kaplan et al. GASTROENTEROLOGY
- Statin use and risk of liver cancer: evidence from two population‐based studies
- (2019) Kim Tu Tran et al. INTERNATIONAL JOURNAL OF CANCER
- Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population
- (2019) Tracey G. Simon et al. ANNALS OF INTERNAL MEDICINE
- Statin Use and the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
- (2019) Myung Ji Goh et al. HEPATOLOGY
- Statin Use is Protective Against Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease
- (2019) Margarita N. German et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- The anti-inflammatory effects of statins on patients with rheumatoid arthritis: A systemic review and meta-analysis of 15 randomized controlled trials
- (2018) Guo-min Li et al. AUTOIMMUNITY REVIEWS
- Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study
- (2018) Gyuri Kim et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Statins decrease the risk of decompensation in hepatitis B virus- and hepatitis C virus-related cirrhosis: A population-based study
- (2017) Fu-Ming Chang et al. HEPATOLOGY
- AASLD guidelines for the treatment of hepatocellular carcinoma
- (2017) Julie K. Heimbach et al. HEPATOLOGY
- Statins Are Associated With a Decreased Risk of Decompensation and Death in Veterans With Hepatitis C–Related Compensated Cirrhosis
- (2016) Arpan Mohanty et al. GASTROENTEROLOGY
- Statins and Reduced Risk of Liver Cancer: Evidence for Confounding: Table 1.
- (2016) Gary D. Friedman et al. JNCI-Journal of the National Cancer Institute
- Trans-arterial radioembolization in intermediate-advanced hepatocellular carcinoma: systematic review and meta-analyses
- (2016) Carla Rognoni et al. Oncotarget
- Statins and Reduced Risk of Liver Cancer: Evidence for Confounding: Table 1.
- (2016) Gary D. Friedman et al. JNCI-Journal of the National Cancer Institute
- Effect of addition of statins to antiviral therapy in hepatitis C virus-infected persons: Results from ERCHIVES
- (2015) Adeel A. Butt et al. HEPATOLOGY
- Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis
- (2015) John Chen Hsiang et al. JOURNAL OF HEPATOLOGY
- Statin Use and Risk of Primary Liver Cancer in the Clinical Practice Research Datalink
- (2015) K. A. McGlynn et al. JNCI-Journal of the National Cancer Institute
- Cancer Risk in HBV Patients With Statin and Metformin Use
- (2015) Chang-I. Chen et al. MEDICINE
- Statin Use and Risk of Primary Liver Cancer in the Clinical Practice Research Datalink
- (2015) K. A. McGlynn et al. JNCI-Journal of the National Cancer Institute
- Statin use and risk of hepatocellular carcinoma in a U.S. population
- (2014) Katherine A. McGlynn et al. Cancer Epidemiology
- Statin treatment reduces the risk of hepatocellular carcinoma but not colon cancer-results from a nationwide case-control study in Sweden
- (2014) Linda Björkhem-Bergman et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Statin use and risk of hepatocellular carcinoma
- (2013) Shih-Wei Lai et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Liver Cancer
- (2013) HEPATOLOGY
- Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection
- (2013) Yu-Tse Tsan et al. JOURNAL OF CLINICAL ONCOLOGY
- Statins Are Associated With a Reduced Risk of Hepatocellular Cancer: A Systematic Review and Meta-analysis
- (2012) Siddharth Singh et al. GASTROENTEROLOGY
- Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection
- (2012) Yu-Tse Tsan et al. JOURNAL OF CLINICAL ONCOLOGY
- The transcription factor KLF2 mediates hepatic endothelial protection and paracrine endothelial–stellate cell deactivation induced by statins
- (2012) Giusi Marrone et al. JOURNAL OF HEPATOLOGY
- Statins and Risk of Cancer
- (2011) Claudio Marelli et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Hepatocellular Carcinoma
- (2011) Hashem B. El-Serag NEW ENGLAND JOURNAL OF MEDICINE
- Antimicrobial and Immunomodulatory Attributes of Statins: Relevance in Solid‐Organ Transplant Recipients
- (2009) Hsin‐Yun Sun et al. CLINICAL INFECTIOUS DISEASES
- Statins Are Associated With a Reduced Risk of Hepatocellular Carcinoma in a Large Cohort of Patients With Diabetes
- (2009) Hashem B. El–Serag et al. GASTROENTEROLOGY
- Pravastatin use and cancer risk: a meta-analysis of individual patient data from long-term prospective controlled trials in Japan
- (2009) Yasuyuki Matsushita et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started